Professor Davis’ research group focuses on the chemical understanding and exploitation of biomolecular function, with an emphasis on carbohydrates and proteins.
Ben Davis was co-founder of Glycoform, a biotechnology company that from 2002-2011 investigated the therapeutic potential of synthetic glycoproteins, and of Oxford Contrast, a company investigating the use of molecular imaging for brain disease. In 2003 he was named among the top young innovators in the world by Technology Review, the Massachusetts Institute of Technology (MIT)'s magazine of innovation in the TR35 awards and was a finalist in the BBSRC Innovator of the Year competition in 2010.
- Drug delivery and gene therapy
- Protein therapeutics